1. Up front

   Up Front 27 February 2019 Pages: 555 - 556

   

2. Referees 2018

   List of Referees 14 February 2019 Pages: 557 - 557

3. Metabolic health in normal-weight and obese individuals

   • Matthias B. Schulze

   Review Open access 19 December 2018 Pages: 558 - 566

   

4. Beta cells in type 1 diabetes: mass and function; sleeping or dead?

   • Richard A. Oram
   • Emily K. Sims
   • Carmella Evans-Molina

   Review Open access 14 February 2019 Pages: 567 - 577

   

5. A future for CD3 antibodies in immunotherapy of type 1 diabetes

   • Lucienne Chatenoud

   Commentary 05 January 2019 Pages: 578 - 581

6. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study

   • Isabelle I. K. Steineck
   • Ajenthen Ranjan
   • Kirsten Nørgaard

   Article 14 January 2019 Pages: 582 - 592

   

7. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide

   • Charles Thivolet
   • Lucien Marchand
   • Karim Chikh

   Article 06 January 2019 Pages: 593 - 597

   

8. Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study

   • William L. Lowe Jr
   • Lynn P. Lowe
   • on behalf of the HAPO Follow-up Study Cooperative Research Group

   Article 15 January 2019 Pages: 598 - 610

   

9. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study

   • Lene R. Madsen
   • Lisbeth M. Baggesen
   • Reimar W. Thomsen

   Article 06 February 2019 Pages: 611 - 620

   

10. The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study

    • Stuart J. McGurnaghan
    • Liam Brierley
    • on behalf of the Scottish Diabetes Research Network Epidemiology Group

    Article Open access 10 January 2019 Pages: 621 - 632

    

11. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study

    • Lasse Bjerg
    • Adam Hulman
    • Marit E. Jørgensen

    Article 16 January 2019 Pages: 633 - 643

    

12. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

    • Ming-Feng Xia
    • Huan-Dong Lin
    • Xin Gao

    Article 23 January 2019 Pages: 644 - 654

    

13. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

    • Ana Luisa Perdigoto
    • Paula Preston-Hurlburt
    • the Immune Tolerance Network

    Article 19 December 2018 Pages: 655 - 664

    

14. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

    • Natasha C. Bergmann
    • Asger Lund
    • Filip K. Knop

    Article 25 January 2019 Pages: 665 - 675

    

15. Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats

    • Rawad Farhat
    • Gong Su
    • Owen Chan

    Article 09 January 2019 Pages: 676 - 686

    

16. The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes

    • Saifur R. Khan
    • Haneesha Mohan
    • Michael B. Wheeler

    Article 15 January 2019 Pages: 687 - 703

    

17. Diurnal rhythms in the white adipose tissue transcriptome are disturbed in obese individuals with type 2 diabetes compared with lean control individuals

    • Dirk Jan Stenvers
    • Aldo Jongejan
    • Peter H. Bisschop

    Article Open access 09 February 2019 Pages: 704 - 716

    

18. Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex

    • Éva A. Csajbók
    • Ágnes K. Kocsis
    • Gábor Tamás

    Article 12 January 2019 Pages: 717 - 725

    

19. Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1

    • Julian Mustroph
    • Charlotte M. Lücht
    • Stefan Wagner

    Research Letter Open access 29 January 2019 Pages: 726 - 729

    

20. Correction to: The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes

    • Saifur R. Khan
    • Haneesha Mohan
    • Michael B. Wheeler

    Correction 08 February 2019 Pages: 730 - 731

    

21. Correction to: Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C

    • S. P. Y. Wong
    • M. Huda
    • J. H. Pinkney

    Correction 29 January 2019 Pages: 732 - 732